About 4-[8-(1,3-oxazol-2-yl)-3-pyrazin-2-yl-4-pyridazin-3-yl-2-pyrimidin-2-yl-6-(thiadiazol-4-yl)-5-(triazin-4-yl)quinolin-7-yl]oxadiazole
4-[8-(1,3-oxazol-2-yl)-3-pyrazin-2-yl-4-pyridazin-3-yl-2-pyrimidin-2-yl-6-(thiadiazol-4-yl)-5-(triazin-4-yl)quinolin-7-yl]oxadiazole (PubChem CID 141374336) has the molecular formula C31H15N15O2S
and a molecular weight of 661.63 g/mol. Its IUPAC name is 4-[8-(1,3-oxazol-2-yl)-3-pyrazin-2-yl-4-pyridazin-3-yl-2-pyrimidin-2-yl-6-(thiadiazol-4-yl)-5-(triazin-4-yl)quinolin-7-yl]oxadiazole.
Molecular Properties
| Compound Name | 4-[8-(1,3-oxazol-2-yl)-3-pyrazin-2-yl-4-pyridazin-3-yl-2-pyrimidin-2-yl-6-(thiadiazol-4-yl)-5-(triazin-4-yl)quinolin-7-yl]oxadiazole |
| PubChem CID | 141374336 |
| Molecular Formula | C31H15N15O2S |
| Molecular Weight | 661.63 g/mol |
| Exact Mass | 661.13 |
| IUPAC Name | 4-[8-(1,3-oxazol-2-yl)-3-pyrazin-2-yl-4-pyridazin-3-yl-2-pyrimidin-2-yl-6-(thiadiazol-4-yl)-5-(triazin-4-yl)quinolin-7-yl]oxadiazole |
| SMILES | c1cnc(-c2nc3c(-c4ncco4)c(-c4conn4)c(-c4csnn4)c(-c4ccnnn4)c3c(-c3cccnn3)c2-c2cnccn2)nc1 |
| InChI | InChI=1S/C31H15N15O2S/c1-3-16(40-37-7-1)22-25(18-13-32-9-10-33-18)29(30-34-5-2-6-35-30)39-28-26(22)21(17-4-8-38-44-41-17)24(20-15-49-46-43-20)23(19-14-48-45-42-19)27(28)31-36-11-12-47-31/h1-15H |
| InChIKey | BNIKBDQUIBABTE-UHFFFAOYSA-N |
| XLogP | 4.68 |
| TPSA | 219.63 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 18 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 49 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
| MW ≤ 500 | 661.63 |
| LogP ≤ 5 | 4.68 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 18 |
Analyze 4-[8-(1,3-oxazol-2-yl)-3-pyrazin-2-yl-4-pyridazin-3-yl-2-pyrimidin-2-yl-6-(thiadiazol-4-yl)-5-(triazin-4-yl)quinolin-7-yl]oxadiazole with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 4-[8-(1,3-oxazol-2-yl)-3-pyrazin-2-yl-4-pyridazin-3-yl-2-pyrimidin-2-yl-6-(thiadiazol-4-yl)-5-(triazin-4-yl)quinolin-7-yl]oxadiazole?
The IUPAC name of 4-[8-(1,3-oxazol-2-yl)-3-pyrazin-2-yl-4-pyridazin-3-yl-2-pyrimidin-2-yl-6-(thiadiazol-4-yl)-5-(triazin-4-yl)quinolin-7-yl]oxadiazole (CID 141374336) is 4-[8-(1,3-oxazol-2-yl)-3-pyrazin-2-yl-4-pyridazin-3-yl-2-pyrimidin-2-yl-6-(thiadiazol-4-yl)-5-(triazin-4-yl)quinolin-7-yl]oxadiazole.
What is the SMILES notation for 4-[8-(1,3-oxazol-2-yl)-3-pyrazin-2-yl-4-pyridazin-3-yl-2-pyrimidin-2-yl-6-(thiadiazol-4-yl)-5-(triazin-4-yl)quinolin-7-yl]oxadiazole?
The canonical SMILES for 4-[8-(1,3-oxazol-2-yl)-3-pyrazin-2-yl-4-pyridazin-3-yl-2-pyrimidin-2-yl-6-(thiadiazol-4-yl)-5-(triazin-4-yl)quinolin-7-yl]oxadiazole is c1cnc(-c2nc3c(-c4ncco4)c(-c4conn4)c(-c4csnn4)c(-c4ccnnn4)c3c(-c3cccnn3)c2-c2cnccn2)nc1.
What is the InChIKey of 4-[8-(1,3-oxazol-2-yl)-3-pyrazin-2-yl-4-pyridazin-3-yl-2-pyrimidin-2-yl-6-(thiadiazol-4-yl)-5-(triazin-4-yl)quinolin-7-yl]oxadiazole?
The InChIKey is BNIKBDQUIBABTE-UHFFFAOYSA-N. The full InChI is InChI=1S/C31H15N15O2S/c1-3-16(40-37-7-1)22-25(18-13-32-9-10-33-18)29(30-34-5-2-6-35-30)39-28-26(22)21(17-4-8-38-44-41-17)24(20-15-49-46-43-20)23(19-14-48-45-42-19)27(28)31-36-11-12-47-31/h1-15H.
What are the key properties of 4-[8-(1,3-oxazol-2-yl)-3-pyrazin-2-yl-4-pyridazin-3-yl-2-pyrimidin-2-yl-6-(thiadiazol-4-yl)-5-(triazin-4-yl)quinolin-7-yl]oxadiazole?
4-[8-(1,3-oxazol-2-yl)-3-pyrazin-2-yl-4-pyridazin-3-yl-2-pyrimidin-2-yl-6-(thiadiazol-4-yl)-5-(triazin-4-yl)quinolin-7-yl]oxadiazole has a molecular weight of 661.63 g/mol, XLogP of 4.68, 7 rotatable bonds, 0 hydrogen bond donors, and 18 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[8-(1,3-oxazol-2-yl)-3-pyrazin-2-yl-4-pyridazin-3-yl-2-pyrimidin-2-yl-6-(thiadiazol-4-yl)-5-(triazin-4-yl)quinolin-7-yl]oxadiazole is sourced from PubChem (CID 141374336), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).